Dianthus Therapeutics (DNTH) PT Raised to $44 at Wedbush
Tweet
Share
E-mailGet Alerts DNTH Hot Sheet
Price: $109.35 +0.79%
Rating Summary:
15 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 6
Rating Summary:
15 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 6
Join SI Premium – FREE
Wedbush analyst Laura Chico raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $44.00 (from $42.00) while maintaining a Outperform rating.
You May Also Be Interested In
- T1 Energy Inc. (TE) PT Raised to $9 at BTIG
- Cineplex (CGX:CN) (CPXGF) PT Raised to Cdn$13.50 at Scotiabank
- H&R REIT (HR-U:CN) PT Raised to Cdn$12 at Scotiabank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
